Yurong Piao , Congli Chen , Di Wu , Min Liu , Wenjing Li , Jiahui Chen , Yanmei Sang
{"title":"四名中国巴特综合征 3 型患者的临床、遗传特征和预后:进一步了解基因型与表型的相关性","authors":"Yurong Piao , Congli Chen , Di Wu , Min Liu , Wenjing Li , Jiahui Chen , Yanmei Sang","doi":"10.1016/j.ymgmr.2024.101112","DOIUrl":null,"url":null,"abstract":"<div><h3>Aim</h3><p>To investigate the characteristics of 4 Chinese patients with Bartter syndrome type 3 (BS Type 3).</p></div><div><h3>Methods</h3><p>The clinical data, genetic analysis, and outcome of four cases with Bartter syndrome type 3 were retrospectively summarised.</p></div><div><h3>Results</h3><p>Gene sequencing analysis showed that all children carried a compound heterozygous mutation in the <em>CLCNKB</em> gene and were diagnosed with BS type 3. All types of mutations were detected, including two missense mutations, one nonsense mutation, one small fragment deletion mutation, two large deletion mutations and one splice-site mutation. The splice-site mutation c.100 + 1 (IVS2) C > T was novel. Two cases carried large deletion mutations. The patients presented as classic BS with modest manifestations. The most common sign was growth retardation. There was no polyhydramnios or preterm delivery. All cases were treated with potassium chloride supplementation and indomethacin. During long-term follow-up, clinical symptoms and growth retardation improved significantly. Nephrocalcinosis or renal dysfunction was not observed.</p></div><div><h3>Conclusion</h3><p>The clinical manifestations of BS type 3 are mostly presented as cBS. Growth retardation is a common sign. BS type 3 had a good long-term prognosis. There were various types of mutations in the <em>CLCNKB</em> gene. Large deletions were the most common.</p></div>","PeriodicalId":18814,"journal":{"name":"Molecular Genetics and Metabolism Reports","volume":"40 ","pages":"Article 101112"},"PeriodicalIF":1.8000,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S221442692400065X/pdfft?md5=11d49e6de3dab159367af1cf443caf1a&pid=1-s2.0-S221442692400065X-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Clinical, genetic characteristics and outcome of four Chinese patients with Bartter syndrome type 3: Further insight into a genotype-phenotype correlation\",\"authors\":\"Yurong Piao , Congli Chen , Di Wu , Min Liu , Wenjing Li , Jiahui Chen , Yanmei Sang\",\"doi\":\"10.1016/j.ymgmr.2024.101112\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Aim</h3><p>To investigate the characteristics of 4 Chinese patients with Bartter syndrome type 3 (BS Type 3).</p></div><div><h3>Methods</h3><p>The clinical data, genetic analysis, and outcome of four cases with Bartter syndrome type 3 were retrospectively summarised.</p></div><div><h3>Results</h3><p>Gene sequencing analysis showed that all children carried a compound heterozygous mutation in the <em>CLCNKB</em> gene and were diagnosed with BS type 3. All types of mutations were detected, including two missense mutations, one nonsense mutation, one small fragment deletion mutation, two large deletion mutations and one splice-site mutation. The splice-site mutation c.100 + 1 (IVS2) C > T was novel. Two cases carried large deletion mutations. The patients presented as classic BS with modest manifestations. The most common sign was growth retardation. There was no polyhydramnios or preterm delivery. All cases were treated with potassium chloride supplementation and indomethacin. During long-term follow-up, clinical symptoms and growth retardation improved significantly. Nephrocalcinosis or renal dysfunction was not observed.</p></div><div><h3>Conclusion</h3><p>The clinical manifestations of BS type 3 are mostly presented as cBS. Growth retardation is a common sign. BS type 3 had a good long-term prognosis. There were various types of mutations in the <em>CLCNKB</em> gene. Large deletions were the most common.</p></div>\",\"PeriodicalId\":18814,\"journal\":{\"name\":\"Molecular Genetics and Metabolism Reports\",\"volume\":\"40 \",\"pages\":\"Article 101112\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2024-07-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S221442692400065X/pdfft?md5=11d49e6de3dab159367af1cf443caf1a&pid=1-s2.0-S221442692400065X-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Genetics and Metabolism Reports\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S221442692400065X\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Genetics and Metabolism Reports","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S221442692400065X","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
摘要
结果基因测序分析显示,所有患儿均携带CLCNKB基因的复合杂合突变,并被诊断为BS 3型。所有类型的突变都被检测到,包括两个错义突变、一个无义突变、一个小片段缺失突变、两个大片段缺失突变和一个剪接位点突变。剪接位点突变 c.100 + 1 (IVS2) C > T 是新出现的。两个病例携带大缺失突变。这些患者表现为典型的 BS,症状轻微。最常见的体征是生长迟缓。没有多胎畸形或早产。所有病例均接受了氯化钾补充剂和吲哚美辛治疗。在长期随访过程中,临床症状和生长迟缓均有明显改善。结论 BS 3 型的临床表现大多为 cBS。结论BS 3 型的长期预后良好。CLCNKB基因存在多种突变。最常见的是大缺失。
Clinical, genetic characteristics and outcome of four Chinese patients with Bartter syndrome type 3: Further insight into a genotype-phenotype correlation
Aim
To investigate the characteristics of 4 Chinese patients with Bartter syndrome type 3 (BS Type 3).
Methods
The clinical data, genetic analysis, and outcome of four cases with Bartter syndrome type 3 were retrospectively summarised.
Results
Gene sequencing analysis showed that all children carried a compound heterozygous mutation in the CLCNKB gene and were diagnosed with BS type 3. All types of mutations were detected, including two missense mutations, one nonsense mutation, one small fragment deletion mutation, two large deletion mutations and one splice-site mutation. The splice-site mutation c.100 + 1 (IVS2) C > T was novel. Two cases carried large deletion mutations. The patients presented as classic BS with modest manifestations. The most common sign was growth retardation. There was no polyhydramnios or preterm delivery. All cases were treated with potassium chloride supplementation and indomethacin. During long-term follow-up, clinical symptoms and growth retardation improved significantly. Nephrocalcinosis or renal dysfunction was not observed.
Conclusion
The clinical manifestations of BS type 3 are mostly presented as cBS. Growth retardation is a common sign. BS type 3 had a good long-term prognosis. There were various types of mutations in the CLCNKB gene. Large deletions were the most common.
期刊介绍:
Molecular Genetics and Metabolism Reports is an open access journal that publishes molecular and metabolic reports describing investigations that use the tools of biochemistry and molecular biology for studies of normal and diseased states. In addition to original research articles, sequence reports, brief communication reports and letters to the editor are considered.